| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| rho-Associated Kinases | 16 | 2022 | 279 | 3.710 |
Why?
|
| Clusterin | 7 | 2020 | 72 | 2.910 |
Why?
|
| Insulin Resistance | 45 | 2020 | 3864 | 2.700 |
Why?
|
| Insulin | 50 | 2020 | 6580 | 1.990 |
Why?
|
| Glucose | 31 | 2020 | 4397 | 1.630 |
Why?
|
| Leptin | 23 | 2021 | 1599 | 1.570 |
Why?
|
| Receptors, Leptin | 7 | 2021 | 360 | 1.420 |
Why?
|
| AMP-Activated Protein Kinases | 6 | 2019 | 611 | 1.420 |
Why?
|
| Agouti-Related Protein | 4 | 2020 | 98 | 1.400 |
Why?
|
| Muscle, Skeletal | 32 | 2020 | 4931 | 1.310 |
Why?
|
| Hypothalamus | 12 | 2021 | 1063 | 1.070 |
Why?
|
| Energy Metabolism | 16 | 2022 | 2899 | 1.050 |
Why?
|
| Obesity | 28 | 2020 | 12745 | 0.990 |
Why?
|
| Signal Transduction | 35 | 2020 | 23403 | 0.940 |
Why?
|
| Physical Conditioning, Animal | 6 | 2021 | 362 | 0.910 |
Why?
|
| Thiazolidinediones | 4 | 2018 | 476 | 0.900 |
Why?
|
| Liver | 20 | 2020 | 7474 | 0.780 |
Why?
|
| Eating | 7 | 2020 | 1536 | 0.760 |
Why?
|
| Anti-Obesity Agents | 4 | 2018 | 217 | 0.750 |
Why?
|
| Diabetes Mellitus, Type 2 | 16 | 2020 | 11725 | 0.720 |
Why?
|
| Overnutrition | 1 | 2018 | 26 | 0.670 |
Why?
|
| Proprotein Convertases | 1 | 2019 | 95 | 0.660 |
Why?
|
| Lipid Metabolism | 6 | 2021 | 1889 | 0.660 |
Why?
|
| PPAR gamma | 7 | 2018 | 493 | 0.660 |
Why?
|
| Blood Glucose | 20 | 2019 | 6256 | 0.650 |
Why?
|
| Phosphatidylinositol 3-Kinases | 17 | 2012 | 2938 | 0.640 |
Why?
|
| Adipocytes | 10 | 2018 | 1184 | 0.620 |
Why?
|
| Resistance Training | 1 | 2020 | 165 | 0.620 |
Why?
|
| Isoenzymes | 9 | 2013 | 1726 | 0.610 |
Why?
|
| Polycystic Ovary Syndrome | 2 | 2020 | 370 | 0.590 |
Why?
|
| Lipogenesis | 1 | 2018 | 212 | 0.580 |
Why?
|
| Glucose Clamp Technique | 9 | 2020 | 266 | 0.540 |
Why?
|
| Dimethyl Sulfoxide | 1 | 2016 | 249 | 0.520 |
Why?
|
| Homeostasis | 11 | 2022 | 3340 | 0.520 |
Why?
|
| Mice, Obese | 8 | 2018 | 424 | 0.510 |
Why?
|
| Kidney Tubules | 1 | 2017 | 488 | 0.510 |
Why?
|
| Hypoglycemic Agents | 8 | 2020 | 2872 | 0.510 |
Why?
|
| Glucose Transporter Type 4 | 8 | 2018 | 250 | 0.500 |
Why?
|
| Sterol Regulatory Element Binding Protein 1 | 2 | 2012 | 137 | 0.490 |
Why?
|
| Mice, Knockout | 24 | 2022 | 14557 | 0.490 |
Why?
|
| Receptor, Insulin | 9 | 2020 | 846 | 0.480 |
Why?
|
| Insulin Receptor Substrate Proteins | 10 | 2012 | 563 | 0.480 |
Why?
|
| Animals | 98 | 2022 | 168757 | 0.470 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 1 | 8 | 2008 | 91 | 0.470 |
Why?
|
| Sulfones | 1 | 2016 | 437 | 0.470 |
Why?
|
| Mice | 69 | 2022 | 81183 | 0.460 |
Why?
|
| Phosphoproteins | 9 | 2011 | 2440 | 0.450 |
Why?
|
| Phosphorylation | 25 | 2021 | 8436 | 0.430 |
Why?
|
| Cysteine Endopeptidases | 4 | 2022 | 563 | 0.430 |
Why?
|
| Peripheral Nervous System | 1 | 2013 | 150 | 0.420 |
Why?
|
| Orphan Nuclear Receptors | 1 | 2012 | 60 | 0.420 |
Why?
|
| Neurons | 6 | 2021 | 9338 | 0.400 |
Why?
|
| Glycogen | 4 | 2013 | 260 | 0.400 |
Why?
|
| Sulfotransferases | 1 | 2012 | 151 | 0.400 |
Why?
|
| Polymerization | 1 | 2012 | 164 | 0.390 |
Why?
|
| Heat-Shock Proteins | 1 | 2015 | 822 | 0.380 |
Why?
|
| Stilbenes | 1 | 2011 | 156 | 0.380 |
Why?
|
| Postmenopause | 1 | 2020 | 2461 | 0.380 |
Why?
|
| 3T3-L1 Cells | 7 | 2018 | 198 | 0.380 |
Why?
|
| Pro-Opiomelanocortin | 3 | 2021 | 163 | 0.370 |
Why?
|
| Dietary Fats | 9 | 2016 | 2017 | 0.360 |
Why?
|
| Diabetic Nephropathies | 1 | 2017 | 984 | 0.360 |
Why?
|
| Autophagy | 2 | 2015 | 1300 | 0.350 |
Why?
|
| Physical Exertion | 2 | 2011 | 695 | 0.350 |
Why?
|
| Neointima | 3 | 2016 | 135 | 0.350 |
Why?
|
| Mice, Inbred C57BL | 21 | 2022 | 21827 | 0.350 |
Why?
|
| Metabolic Diseases | 1 | 2016 | 658 | 0.350 |
Why?
|
| Carotid Artery Injuries | 3 | 2016 | 96 | 0.340 |
Why?
|
| Protein Kinase C | 4 | 2006 | 1227 | 0.330 |
Why?
|
| Protein Tyrosine Phosphatases | 7 | 2007 | 473 | 0.330 |
Why?
|
| Fatty Acids | 5 | 2019 | 1809 | 0.330 |
Why?
|
| Nitric Oxide Synthase Type II | 3 | 2018 | 534 | 0.320 |
Why?
|
| Exercise | 4 | 2020 | 5615 | 0.320 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 2 | 2002 | 494 | 0.310 |
Why?
|
| Gene Expression | 8 | 2020 | 7799 | 0.300 |
Why?
|
| Glycogen Synthase Kinase 3 | 5 | 2015 | 430 | 0.300 |
Why?
|
| Obesity, Abdominal | 1 | 2010 | 361 | 0.290 |
Why?
|
| Small Ubiquitin-Related Modifier Proteins | 2 | 2022 | 72 | 0.290 |
Why?
|
| Carrier Proteins | 5 | 2015 | 5021 | 0.290 |
Why?
|
| Quinolines | 1 | 2012 | 732 | 0.280 |
Why?
|
| Proto-Oncogene Proteins | 7 | 2002 | 4554 | 0.280 |
Why?
|
| Monosaccharide Transport Proteins | 4 | 2002 | 440 | 0.270 |
Why?
|
| Fatty Liver | 1 | 2012 | 727 | 0.270 |
Why?
|
| Seaweed | 2 | 2016 | 28 | 0.270 |
Why?
|
| Gene Deletion | 1 | 2013 | 2751 | 0.270 |
Why?
|
| Hyperinsulinism | 5 | 2017 | 415 | 0.260 |
Why?
|
| Actins | 2 | 2012 | 2121 | 0.260 |
Why?
|
| Insulin-Secreting Cells | 4 | 2021 | 891 | 0.260 |
Why?
|
| Sirtuins | 1 | 2007 | 323 | 0.250 |
Why?
|
| Bone Density Conservation Agents | 1 | 2012 | 773 | 0.240 |
Why?
|
| Adipogenesis | 3 | 2022 | 359 | 0.240 |
Why?
|
| Adipose Tissue | 11 | 2016 | 3279 | 0.240 |
Why?
|
| Rats | 26 | 2016 | 24260 | 0.240 |
Why?
|
| Male | 71 | 2022 | 350118 | 0.240 |
Why?
|
| Rats, Sprague-Dawley | 16 | 2020 | 8301 | 0.240 |
Why?
|
| Retinol-Binding Proteins, Plasma | 3 | 2009 | 93 | 0.240 |
Why?
|
| Motor Activity | 2 | 2013 | 2714 | 0.230 |
Why?
|
| Proto-Oncogene Proteins c-akt | 11 | 2016 | 2503 | 0.230 |
Why?
|
| STAT3 Transcription Factor | 5 | 2013 | 873 | 0.230 |
Why?
|
| Metformin | 3 | 2019 | 835 | 0.230 |
Why?
|
| CCAAT-Enhancer-Binding Protein-beta | 2 | 2022 | 103 | 0.220 |
Why?
|
| Diabetes Mellitus, Experimental | 3 | 2019 | 1116 | 0.220 |
Why?
|
| Glucose Intolerance | 4 | 2019 | 577 | 0.220 |
Why?
|
| Insulin Antagonists | 1 | 2002 | 20 | 0.220 |
Why?
|
| Gluconeogenesis | 4 | 2020 | 183 | 0.210 |
Why?
|
| Muscles | 5 | 2007 | 1614 | 0.210 |
Why?
|
| Sulfonamides | 1 | 2012 | 1938 | 0.210 |
Why?
|
| Peptide Fragments | 2 | 2013 | 5097 | 0.210 |
Why?
|
| Chromans | 1 | 2002 | 122 | 0.200 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2011 | 1790 | 0.200 |
Why?
|
| Pancreas | 2 | 2021 | 1686 | 0.200 |
Why?
|
| Tyrosine | 6 | 2010 | 1461 | 0.200 |
Why?
|
| Lipids | 2 | 2012 | 3305 | 0.200 |
Why?
|
| Cells, Cultured | 13 | 2019 | 19229 | 0.200 |
Why?
|
| Rats, Inbred OLETF | 7 | 2016 | 8 | 0.200 |
Why?
|
| Glycogen Synthase | 4 | 2013 | 62 | 0.190 |
Why?
|
| Trans-Activators | 6 | 2016 | 2924 | 0.190 |
Why?
|
| Energy Intake | 5 | 2018 | 2148 | 0.190 |
Why?
|
| Gene Silencing | 1 | 2007 | 1538 | 0.190 |
Why?
|
| Adiponectin | 5 | 2012 | 1100 | 0.190 |
Why?
|
| Fructose-Bisphosphatase | 1 | 2020 | 24 | 0.190 |
Why?
|
| Arabidopsis Proteins | 1 | 2002 | 262 | 0.190 |
Why?
|
| Cold-Shock Response | 1 | 2020 | 16 | 0.180 |
Why?
|
| Body Weight | 15 | 2018 | 4669 | 0.180 |
Why?
|
| Plant Proteins | 1 | 2002 | 364 | 0.180 |
Why?
|
| Mice, Transgenic | 10 | 2021 | 9734 | 0.180 |
Why?
|
| Adipose Tissue, White | 4 | 2022 | 351 | 0.170 |
Why?
|
| Potassium Channels | 1 | 2002 | 563 | 0.170 |
Why?
|
| Palmitates | 1 | 2019 | 74 | 0.170 |
Why?
|
| Muscle, Smooth, Vascular | 6 | 2022 | 1504 | 0.170 |
Why?
|
| Glucosamine | 1 | 1999 | 132 | 0.160 |
Why?
|
| Minerals | 1 | 2020 | 275 | 0.160 |
Why?
|
| Diabetes Mellitus | 7 | 2021 | 5751 | 0.160 |
Why?
|
| Cell Line | 9 | 2020 | 15997 | 0.160 |
Why?
|
| Diet | 4 | 2020 | 7939 | 0.160 |
Why?
|
| Myocytes, Smooth Muscle | 4 | 2022 | 687 | 0.160 |
Why?
|
| Water Pollutants, Chemical | 1 | 2022 | 311 | 0.160 |
Why?
|
| Muscle Fibers, Skeletal | 4 | 2019 | 555 | 0.160 |
Why?
|
| Protective Agents | 1 | 2019 | 156 | 0.160 |
Why?
|
| Gene Expression Regulation | 9 | 2018 | 12072 | 0.160 |
Why?
|
| Muscle Proteins | 3 | 2002 | 1159 | 0.150 |
Why?
|
| Down-Regulation | 3 | 2018 | 3002 | 0.150 |
Why?
|
| rho GTP-Binding Proteins | 2 | 2010 | 293 | 0.150 |
Why?
|
| Calcium, Dietary | 1 | 2020 | 526 | 0.150 |
Why?
|
| Safflower Oil | 1 | 1996 | 29 | 0.150 |
Why?
|
| Carbohydrate Metabolism | 1 | 2018 | 264 | 0.150 |
Why?
|
| Carotid Artery, External | 1 | 2016 | 38 | 0.140 |
Why?
|
| Intestinal Absorption | 1 | 2018 | 420 | 0.140 |
Why?
|
| Protein Phosphatase 1 | 3 | 2013 | 137 | 0.140 |
Why?
|
| Glucose Tolerance Test | 8 | 2015 | 1150 | 0.140 |
Why?
|
| Inflammation | 7 | 2020 | 10638 | 0.140 |
Why?
|
| Fats | 1 | 1996 | 102 | 0.140 |
Why?
|
| Fructose | 1 | 2018 | 288 | 0.140 |
Why?
|
| Triglycerides | 5 | 2016 | 2454 | 0.140 |
Why?
|
| Biological Transport | 5 | 2012 | 2118 | 0.130 |
Why?
|
| Mitogen-Activated Protein Kinases | 3 | 2004 | 1285 | 0.130 |
Why?
|
| Fibroblast Growth Factors | 2 | 2013 | 879 | 0.130 |
Why?
|
| Mice, Mutant Strains | 4 | 2014 | 1866 | 0.130 |
Why?
|
| Animal Feed | 3 | 2020 | 110 | 0.130 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2016 | 1676 | 0.130 |
Why?
|
| Glucokinase | 1 | 1995 | 103 | 0.130 |
Why?
|
| Female | 31 | 2020 | 380194 | 0.120 |
Why?
|
| Carboxylic Acids | 1 | 2015 | 97 | 0.120 |
Why?
|
| Islets of Langerhans | 3 | 2007 | 1352 | 0.120 |
Why?
|
| Thiazoles | 1 | 2002 | 1483 | 0.120 |
Why?
|
| Enzyme Activation | 6 | 2010 | 3701 | 0.120 |
Why?
|
| Glucagon-Like Peptide 1 | 1 | 2016 | 340 | 0.120 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 5 | 2009 | 2915 | 0.120 |
Why?
|
| Atherosclerosis | 3 | 2016 | 3445 | 0.120 |
Why?
|
| Pancreatic Ducts | 1 | 2016 | 328 | 0.120 |
Why?
|
| Cholesterol | 4 | 2016 | 2917 | 0.120 |
Why?
|
| Apolipoproteins E | 2 | 2016 | 1438 | 0.120 |
Why?
|
| bcl-Associated Death Protein | 1 | 2014 | 107 | 0.120 |
Why?
|
| Adenoviridae | 2 | 2016 | 1099 | 0.120 |
Why?
|
| Mitochondrial Proteins | 4 | 2006 | 996 | 0.110 |
Why?
|
| Organ Specificity | 4 | 2013 | 2008 | 0.110 |
Why?
|
| Crosses, Genetic | 2 | 2013 | 791 | 0.110 |
Why?
|
| Dietary Carbohydrates | 3 | 1996 | 906 | 0.110 |
Why?
|
| Anorexia | 2 | 2013 | 161 | 0.110 |
Why?
|
| Albuminuria | 1 | 2017 | 682 | 0.110 |
Why?
|
| Multienzyme Complexes | 2 | 2010 | 686 | 0.110 |
Why?
|
| Tunica Intima | 2 | 2012 | 464 | 0.110 |
Why?
|
| Exercise Therapy | 1 | 2020 | 906 | 0.110 |
Why?
|
| Alternative Splicing | 2 | 1995 | 1117 | 0.110 |
Why?
|
| Body Composition | 3 | 2020 | 2401 | 0.110 |
Why?
|
| Glucosides | 1 | 2016 | 451 | 0.110 |
Why?
|
| Gene Transfer Techniques | 2 | 2016 | 1224 | 0.110 |
Why?
|
| Fasting | 5 | 2018 | 1593 | 0.110 |
Why?
|
| Trimetazidine | 1 | 2012 | 2 | 0.110 |
Why?
|
| Irritable Bowel Syndrome | 1 | 2018 | 445 | 0.110 |
Why?
|
| Postprandial Period | 1 | 2014 | 292 | 0.110 |
Why?
|
| Serum Amyloid P-Component | 1 | 2012 | 47 | 0.110 |
Why?
|
| Humans | 50 | 2020 | 744343 | 0.100 |
Why?
|
| Phosphoprotein Phosphatases | 2 | 2005 | 337 | 0.100 |
Why?
|
| Disease Models, Animal | 9 | 2020 | 18029 | 0.100 |
Why?
|
| Appetite Regulation | 1 | 2012 | 88 | 0.100 |
Why?
|
| Macrophages | 2 | 2018 | 5655 | 0.100 |
Why?
|
| Bilirubin | 1 | 2014 | 425 | 0.100 |
Why?
|
| Microglia | 1 | 2020 | 1266 | 0.100 |
Why?
|
| Homeodomain Proteins | 2 | 2018 | 2421 | 0.100 |
Why?
|
| Ginkgo biloba | 1 | 2011 | 26 | 0.100 |
Why?
|
| Brain | 2 | 2021 | 26385 | 0.100 |
Why?
|
| Myoblasts, Skeletal | 1 | 2012 | 76 | 0.100 |
Why?
|
| Myeloid Cells | 1 | 2016 | 810 | 0.100 |
Why?
|
| Carotid Arteries | 2 | 2015 | 952 | 0.100 |
Why?
|
| Vagus Nerve | 1 | 2014 | 438 | 0.100 |
Why?
|
| Aminopyridines | 1 | 2015 | 542 | 0.100 |
Why?
|
| Glycogen Phosphorylase | 2 | 2013 | 16 | 0.100 |
Why?
|
| Actin Depolymerizing Factors | 1 | 2010 | 43 | 0.100 |
Why?
|
| Diarrhea | 1 | 2018 | 1348 | 0.100 |
Why?
|
| Biotransformation | 1 | 2010 | 168 | 0.100 |
Why?
|
| Janus Kinase 2 | 2 | 2012 | 528 | 0.100 |
Why?
|
| Blotting, Western | 4 | 2016 | 5179 | 0.100 |
Why?
|
| Abdominal Fat | 2 | 2009 | 223 | 0.090 |
Why?
|
| Behavior, Animal | 2 | 2022 | 1881 | 0.090 |
Why?
|
| Benzhydryl Compounds | 1 | 2016 | 845 | 0.090 |
Why?
|
| Zebrafish | 1 | 2022 | 2994 | 0.090 |
Why?
|
| Angiopoietins | 1 | 2010 | 80 | 0.090 |
Why?
|
| Coronary Stenosis | 1 | 2016 | 834 | 0.090 |
Why?
|
| Transcription Factors | 4 | 2018 | 12208 | 0.090 |
Why?
|
| Ventromedial Hypothalamic Nucleus | 1 | 2009 | 48 | 0.090 |
Why?
|
| Hypertriglyceridemia | 1 | 2013 | 293 | 0.090 |
Why?
|
| Femur | 1 | 2016 | 1297 | 0.090 |
Why?
|
| Mitochondria | 3 | 2021 | 3520 | 0.090 |
Why?
|
| Membrane Proteins | 4 | 2016 | 7880 | 0.090 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2010 | 241 | 0.090 |
Why?
|
| Endocytosis | 1 | 2014 | 985 | 0.090 |
Why?
|
| RNA, Small Interfering | 5 | 2016 | 3505 | 0.090 |
Why?
|
| S-Adenosylmethionine | 1 | 2011 | 212 | 0.090 |
Why?
|
| Glomerular Filtration Rate | 1 | 2017 | 2170 | 0.090 |
Why?
|
| Calcium-Binding Proteins | 4 | 2016 | 1081 | 0.090 |
Why?
|
| Peritoneal Dialysis | 1 | 2010 | 146 | 0.080 |
Why?
|
| Lipodystrophy, Familial Partial | 1 | 2008 | 3 | 0.080 |
Why?
|
| Coronary Restenosis | 1 | 2012 | 424 | 0.080 |
Why?
|
| Bone and Bones | 1 | 2020 | 2575 | 0.080 |
Why?
|
| Apoptosis | 7 | 2016 | 9727 | 0.080 |
Why?
|
| Receptors, Adrenergic, beta | 1 | 2009 | 246 | 0.080 |
Why?
|
| NF-kappa B | 3 | 2015 | 2499 | 0.080 |
Why?
|
| Ribosomal Protein S6 Kinases | 1 | 2009 | 205 | 0.080 |
Why?
|
| Particulate Matter | 1 | 2020 | 2530 | 0.080 |
Why?
|
| Gene Expression Regulation, Enzymologic | 3 | 2011 | 1213 | 0.080 |
Why?
|
| Imidazoles | 1 | 2015 | 1206 | 0.080 |
Why?
|
| Parasympathetic Nervous System | 1 | 2009 | 141 | 0.080 |
Why?
|
| Thermogenesis | 3 | 2022 | 435 | 0.080 |
Why?
|
| Middle Aged | 13 | 2020 | 213383 | 0.080 |
Why?
|
| Pericardium | 1 | 2013 | 667 | 0.080 |
Why?
|
| Feeding Behavior | 3 | 2013 | 3188 | 0.080 |
Why?
|
| Recombinant Fusion Proteins | 3 | 2013 | 3772 | 0.080 |
Why?
|
| Nerve Tissue Proteins | 2 | 2013 | 4462 | 0.080 |
Why?
|
| Proteins | 3 | 2001 | 6103 | 0.080 |
Why?
|
| Dipeptidyl-Peptidase IV Inhibitors | 1 | 2012 | 293 | 0.080 |
Why?
|
| Hepatitis B virus | 1 | 2011 | 513 | 0.080 |
Why?
|
| Cell Differentiation | 5 | 2018 | 11483 | 0.080 |
Why?
|
| Plant Extracts | 1 | 2011 | 471 | 0.080 |
Why?
|
| Coenzyme A Ligases | 2 | 2019 | 43 | 0.070 |
Why?
|
| Lipase | 1 | 2009 | 314 | 0.070 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2013 | 1157 | 0.070 |
Why?
|
| Physical Education and Training | 2 | 2011 | 106 | 0.070 |
Why?
|
| Random Allocation | 1 | 2012 | 2429 | 0.070 |
Why?
|
| Carnitine O-Palmitoyltransferase | 2 | 2019 | 86 | 0.070 |
Why?
|
| Kinetics | 2 | 2010 | 6473 | 0.070 |
Why?
|
| Hyperglycemia | 3 | 2011 | 1373 | 0.070 |
Why?
|
| Injections, Intraventricular | 2 | 2013 | 230 | 0.070 |
Why?
|
| Synaptic Transmission | 1 | 2013 | 1178 | 0.070 |
Why?
|
| C-Reactive Protein | 3 | 2015 | 3778 | 0.070 |
Why?
|
| Genetic Vectors | 1 | 2016 | 3420 | 0.070 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2008 | 452 | 0.070 |
Why?
|
| Peptide Hydrolases | 1 | 2010 | 634 | 0.070 |
Why?
|
| Calcium | 1 | 2020 | 5756 | 0.070 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2008 | 2916 | 0.070 |
Why?
|
| RNA, Messenger | 9 | 2010 | 13033 | 0.070 |
Why?
|
| Air Pollution | 1 | 2020 | 2286 | 0.070 |
Why?
|
| Angioplasty, Balloon | 1 | 2011 | 653 | 0.070 |
Why?
|
| Sequence Homology, Nucleic Acid | 2 | 1999 | 1085 | 0.070 |
Why?
|
| Models, Biological | 4 | 2019 | 9583 | 0.070 |
Why?
|
| Adult | 14 | 2020 | 214055 | 0.070 |
Why?
|
| DNA, Mitochondrial | 1 | 2011 | 817 | 0.070 |
Why?
|
| Cell Proliferation | 7 | 2018 | 10481 | 0.070 |
Why?
|
| Triazoles | 1 | 2012 | 911 | 0.070 |
Why?
|
| Cell Survival | 5 | 2019 | 5882 | 0.070 |
Why?
|
| Liver Glycogen | 1 | 2005 | 34 | 0.070 |
Why?
|
| Glucose-6-Phosphate | 1 | 2005 | 30 | 0.070 |
Why?
|
| Sirtuin 1 | 1 | 2007 | 246 | 0.070 |
Why?
|
| Mitochondria, Liver | 1 | 2006 | 187 | 0.070 |
Why?
|
| Adaptation, Physiological | 1 | 2013 | 1312 | 0.070 |
Why?
|
| Pyrazines | 1 | 2012 | 1230 | 0.070 |
Why?
|
| GTPase-Activating Proteins | 1 | 2009 | 498 | 0.070 |
Why?
|
| Mitochondria, Muscle | 1 | 2006 | 171 | 0.070 |
Why?
|
| Heart | 3 | 2009 | 4467 | 0.070 |
Why?
|
| Diabetic Neuropathies | 1 | 2009 | 400 | 0.070 |
Why?
|
| Hexokinase | 1 | 2005 | 125 | 0.060 |
Why?
|
| Models, Animal | 1 | 2012 | 2171 | 0.060 |
Why?
|
| Stress, Physiological | 1 | 2013 | 1403 | 0.060 |
Why?
|
| Membrane Transport Proteins | 2 | 2001 | 1028 | 0.060 |
Why?
|
| Action Potentials | 1 | 2012 | 1806 | 0.060 |
Why?
|
| Cytoskeletal Proteins | 1 | 2010 | 1364 | 0.060 |
Why?
|
| Osmolar Concentration | 2 | 2019 | 683 | 0.060 |
Why?
|
| Tumor Necrosis Factor-alpha | 4 | 2015 | 4420 | 0.060 |
Why?
|
| Transcription Factor RelA | 2 | 2016 | 275 | 0.060 |
Why?
|
| Cell Communication | 2 | 2013 | 1621 | 0.060 |
Why?
|
| 3T3 Cells | 3 | 2001 | 1101 | 0.060 |
Why?
|
| Carotid Artery Diseases | 1 | 2011 | 882 | 0.060 |
Why?
|
| DNA, Complementary | 2 | 1999 | 2050 | 0.060 |
Why?
|
| PPAR alpha | 1 | 2005 | 197 | 0.060 |
Why?
|
| Cell Line, Tumor | 7 | 2021 | 16689 | 0.060 |
Why?
|
| Case-Control Studies | 3 | 2017 | 21746 | 0.060 |
Why?
|
| Neuropeptides | 1 | 2009 | 942 | 0.060 |
Why?
|
| Cell Adhesion Molecules | 3 | 2015 | 1602 | 0.060 |
Why?
|
| Protein Kinase C-epsilon | 1 | 2003 | 43 | 0.060 |
Why?
|
| Oxidation-Reduction | 3 | 2019 | 2187 | 0.060 |
Why?
|
| Adenylate Kinase | 1 | 2004 | 100 | 0.060 |
Why?
|
| Transfection | 4 | 2019 | 5892 | 0.060 |
Why?
|
| Ultraviolet Rays | 1 | 2008 | 1060 | 0.060 |
Why?
|
| Base Sequence | 4 | 2008 | 12797 | 0.060 |
Why?
|
| Risk Factors | 4 | 2020 | 72290 | 0.060 |
Why?
|
| Cell Adhesion | 3 | 2016 | 3144 | 0.060 |
Why?
|
| Phosphatidylinositol Phosphates | 1 | 2004 | 209 | 0.060 |
Why?
|
| Peptide Hormones | 1 | 2004 | 134 | 0.060 |
Why?
|
| Molecular Sequence Data | 5 | 2008 | 18111 | 0.060 |
Why?
|
| STAT1 Transcription Factor | 2 | 2004 | 320 | 0.060 |
Why?
|
| Pyrimidines | 1 | 2015 | 2942 | 0.060 |
Why?
|
| Protein Kinase C-alpha | 1 | 2003 | 112 | 0.060 |
Why?
|
| Deoxyglucose | 2 | 2001 | 337 | 0.060 |
Why?
|
| Phosphotransferases | 1 | 2004 | 308 | 0.060 |
Why?
|
| Nuclear Proteins | 1 | 2018 | 5853 | 0.060 |
Why?
|
| Neoplasm Proteins | 1 | 2015 | 3703 | 0.060 |
Why?
|
| Collagen | 1 | 2011 | 2689 | 0.060 |
Why?
|
| B-Lymphocytes | 1 | 2016 | 4665 | 0.050 |
Why?
|
| Glycogen Synthase Kinases | 1 | 2002 | 40 | 0.050 |
Why?
|
| Immunoblotting | 3 | 2013 | 1682 | 0.050 |
Why?
|
| Abdomen | 1 | 2008 | 1118 | 0.050 |
Why?
|
| Proinsulin | 2 | 2009 | 133 | 0.050 |
Why?
|
| Aged | 8 | 2020 | 163280 | 0.050 |
Why?
|
| MAP Kinase Signaling System | 2 | 2016 | 1526 | 0.050 |
Why?
|
| Time Factors | 8 | 2020 | 40075 | 0.050 |
Why?
|
| Polysaccharides | 1 | 2009 | 1053 | 0.050 |
Why?
|
| Hypertrophy, Right Ventricular | 1 | 2022 | 110 | 0.050 |
Why?
|
| Early Detection of Cancer | 1 | 2015 | 3086 | 0.050 |
Why?
|
| Cricetinae | 1 | 2005 | 2472 | 0.050 |
Why?
|
| Coronary Vessels | 1 | 2013 | 3107 | 0.050 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2018 | 5535 | 0.050 |
Why?
|
| Tissue Distribution | 2 | 2009 | 2327 | 0.050 |
Why?
|
| Glycerol | 1 | 2002 | 278 | 0.050 |
Why?
|
| Chemokine CCL2 | 2 | 2015 | 617 | 0.050 |
Why?
|
| Radiation Injuries | 1 | 2008 | 1180 | 0.050 |
Why?
|
| Protein Isoforms | 2 | 2004 | 1730 | 0.050 |
Why?
|
| Body Mass Index | 3 | 2012 | 12720 | 0.050 |
Why?
|
| beta Catenin | 1 | 2006 | 1059 | 0.050 |
Why?
|
| Phytic Acid | 1 | 2020 | 23 | 0.050 |
Why?
|
| Myocardium | 4 | 2009 | 4776 | 0.050 |
Why?
|
| Transgenes | 1 | 2004 | 1009 | 0.050 |
Why?
|
| Disease Progression | 1 | 2017 | 13284 | 0.050 |
Why?
|
| Rats, Zucker | 1 | 2000 | 128 | 0.050 |
Why?
|
| Hormones | 1 | 2004 | 889 | 0.040 |
Why?
|
| Hyperphagia | 1 | 2020 | 136 | 0.040 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2002 | 1801 | 0.040 |
Why?
|
| Multifactorial Inheritance | 1 | 2007 | 1194 | 0.040 |
Why?
|
| Organ Size | 2 | 2009 | 2252 | 0.040 |
Why?
|
| Adipocytes, Brown | 1 | 2020 | 144 | 0.040 |
Why?
|
| src Homology Domains | 1 | 2000 | 364 | 0.040 |
Why?
|
| Endothelium, Vascular | 1 | 2012 | 4456 | 0.040 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 2 | 2004 | 437 | 0.040 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2004 | 986 | 0.040 |
Why?
|
| Adiposity | 1 | 2009 | 1807 | 0.040 |
Why?
|
| I-kappa B Kinase | 1 | 2020 | 252 | 0.040 |
Why?
|
| Phosphorus | 1 | 2020 | 338 | 0.040 |
Why?
|
| Forkhead Transcription Factors | 1 | 2006 | 1613 | 0.040 |
Why?
|
| Bone Density | 1 | 2012 | 3468 | 0.040 |
Why?
|
| Exons | 2 | 1995 | 2437 | 0.040 |
Why?
|
| Interleukin-10 | 1 | 2004 | 1200 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2012 | 10943 | 0.040 |
Why?
|
| Diabetes, Gestational | 1 | 2008 | 1184 | 0.040 |
Why?
|
| 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine | 1 | 2018 | 57 | 0.040 |
Why?
|
| HLA Antigens | 1 | 2004 | 1381 | 0.040 |
Why?
|
| Glycolysis | 1 | 2002 | 827 | 0.040 |
Why?
|
| Interleukin-6 | 2 | 2007 | 3200 | 0.040 |
Why?
|
| Breast Neoplasms | 2 | 2015 | 20822 | 0.040 |
Why?
|
| Neurotransmitter Agents | 1 | 2022 | 647 | 0.040 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2011 | 4751 | 0.040 |
Why?
|
| Zinc | 1 | 2022 | 684 | 0.040 |
Why?
|
| Ecosystem | 1 | 2022 | 474 | 0.040 |
Why?
|
| Fatty Acids, Nonesterified | 2 | 2001 | 402 | 0.040 |
Why?
|
| Kidney Failure, Chronic | 1 | 2010 | 2538 | 0.040 |
Why?
|
| Lactic Acid | 1 | 2002 | 1133 | 0.040 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2020 | 565 | 0.040 |
Why?
|
| DNA Damage | 1 | 2006 | 2432 | 0.040 |
Why?
|
| Immunohistochemistry | 4 | 2015 | 11366 | 0.040 |
Why?
|
| Protein Binding | 3 | 2014 | 9386 | 0.040 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 2018 | 286 | 0.040 |
Why?
|
| Prealbumin | 2 | 2008 | 210 | 0.040 |
Why?
|
| Phosphates | 1 | 2020 | 786 | 0.040 |
Why?
|
| Venoms | 1 | 2016 | 91 | 0.030 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2006 | 2948 | 0.030 |
Why?
|
| Phenotype | 3 | 2022 | 16365 | 0.030 |
Why?
|
| Fatty Acid-Binding Proteins | 1 | 2018 | 300 | 0.030 |
Why?
|
| Adipose Tissue, Brown | 1 | 2022 | 757 | 0.030 |
Why?
|
| Incretins | 1 | 2016 | 88 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinase 6 | 1 | 1995 | 11 | 0.030 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2018 | 315 | 0.030 |
Why?
|
| Macrophage Activation | 1 | 2018 | 558 | 0.030 |
Why?
|
| Glucose Transporter Type 2 | 1 | 1995 | 62 | 0.030 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2016 | 294 | 0.030 |
Why?
|
| DNA-Binding Proteins | 2 | 2004 | 9648 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 2 | 1995 | 6171 | 0.030 |
Why?
|
| PPAR delta | 1 | 2015 | 43 | 0.030 |
Why?
|
| Amides | 1 | 2018 | 459 | 0.030 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2009 | 3336 | 0.030 |
Why?
|
| Oxidative Stress | 2 | 2019 | 3086 | 0.030 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2019 | 783 | 0.030 |
Why?
|
| Palmitic Acid | 1 | 2015 | 154 | 0.030 |
Why?
|
| Kidney | 1 | 2010 | 7186 | 0.030 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2016 | 472 | 0.030 |
Why?
|
| rab GTP-Binding Proteins | 1 | 2016 | 246 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2019 | 1655 | 0.030 |
Why?
|
| Republic of Korea | 1 | 2016 | 539 | 0.030 |
Why?
|
| Protein Denaturation | 1 | 2014 | 237 | 0.030 |
Why?
|
| Phytotherapy | 1 | 2016 | 298 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 1995 | 480 | 0.030 |
Why?
|
| Sympathetic Nervous System | 2 | 2009 | 514 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 1995 | 489 | 0.030 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2016 | 625 | 0.030 |
Why?
|
| Pulmonary Artery | 1 | 2022 | 1912 | 0.030 |
Why?
|
| Choroid | 1 | 2015 | 322 | 0.030 |
Why?
|
| Reference Values | 1 | 2000 | 4982 | 0.030 |
Why?
|
| GTP Phosphohydrolases | 1 | 2016 | 509 | 0.030 |
Why?
|
| Proteomics | 2 | 2016 | 3638 | 0.030 |
Why?
|
| Heart Diseases | 1 | 2005 | 2788 | 0.030 |
Why?
|
| Starvation | 1 | 2013 | 134 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 2 | 2013 | 1434 | 0.030 |
Why?
|
| Blood-Brain Barrier | 1 | 2018 | 1017 | 0.030 |
Why?
|
| Weight Loss | 1 | 2003 | 2622 | 0.030 |
Why?
|
| Ginkgolides | 1 | 2011 | 4 | 0.030 |
Why?
|
| Cell Movement | 2 | 2016 | 5217 | 0.030 |
Why?
|
| Phosphotyrosine | 2 | 2004 | 457 | 0.030 |
Why?
|
| Endothelium-Dependent Relaxing Factors | 1 | 2011 | 19 | 0.030 |
Why?
|
| Kaempferols | 1 | 2011 | 21 | 0.030 |
Why?
|
| Ion Channels | 3 | 2001 | 1056 | 0.030 |
Why?
|
| Phagosomes | 1 | 2013 | 193 | 0.030 |
Why?
|
| Choroidal Neovascularization | 1 | 2015 | 343 | 0.030 |
Why?
|
| Reactive Oxygen Species | 1 | 2019 | 2077 | 0.030 |
Why?
|
| Cell Polarity | 1 | 2015 | 645 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 8 | 1 | 2011 | 77 | 0.020 |
Why?
|
| Glutathione | 1 | 2014 | 589 | 0.020 |
Why?
|
| Heme Oxygenase-1 | 1 | 2014 | 381 | 0.020 |
Why?
|
| Cyclopentanes | 1 | 2011 | 91 | 0.020 |
Why?
|
| Rats, Long-Evans | 1 | 2012 | 387 | 0.020 |
Why?
|
| Viral Regulatory and Accessory Proteins | 1 | 2011 | 159 | 0.020 |
Why?
|
| U937 Cells | 1 | 2011 | 268 | 0.020 |
Why?
|
| Epididymis | 1 | 2013 | 227 | 0.020 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 2012 | 281 | 0.020 |
Why?
|
| Quercetin | 1 | 2011 | 93 | 0.020 |
Why?
|
| DNA Primers | 1 | 1995 | 2892 | 0.020 |
Why?
|
| Analysis of Variance | 2 | 2012 | 6365 | 0.020 |
Why?
|
| Sequence Analysis, RNA | 1 | 2018 | 2012 | 0.020 |
Why?
|
| Cattle | 1 | 1996 | 3922 | 0.020 |
Why?
|
| Hep G2 Cells | 1 | 2011 | 393 | 0.020 |
Why?
|
| Furans | 1 | 2011 | 194 | 0.020 |
Why?
|
| Sympathomimetics | 1 | 2009 | 57 | 0.020 |
Why?
|
| Korea | 1 | 2009 | 99 | 0.020 |
Why?
|
| Receptors, G-Protein-Coupled | 2 | 2009 | 1222 | 0.020 |
Why?
|
| CCAAT-Enhancer-Binding Protein-alpha | 1 | 2010 | 130 | 0.020 |
Why?
|
| G Protein-Coupled Inwardly-Rectifying Potassium Channels | 1 | 2009 | 64 | 0.020 |
Why?
|
| Enzyme Inhibitors | 2 | 2016 | 3798 | 0.020 |
Why?
|
| Receptors, Neuropeptide | 1 | 2009 | 111 | 0.020 |
Why?
|
| COS Cells | 2 | 2002 | 1161 | 0.020 |
Why?
|
| Cholinergic Agents | 1 | 2009 | 93 | 0.020 |
Why?
|
| Carbachol | 1 | 2009 | 226 | 0.020 |
Why?
|
| Caspase 3 | 1 | 2011 | 758 | 0.020 |
Why?
|
| Albumins | 1 | 2011 | 569 | 0.020 |
Why?
|
| Response Elements | 1 | 2010 | 312 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2015 | 3870 | 0.020 |
Why?
|
| Protein Stability | 1 | 2010 | 557 | 0.020 |
Why?
|
| ROC Curve | 1 | 2015 | 3527 | 0.020 |
Why?
|
| Endoplasmic Reticulum | 1 | 2014 | 1144 | 0.020 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2010 | 491 | 0.020 |
Why?
|
| Gene Targeting | 2 | 2001 | 880 | 0.020 |
Why?
|
| Aorta | 1 | 2015 | 2061 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 2015 | 3616 | 0.020 |
Why?
|
| Macular Degeneration | 1 | 2015 | 980 | 0.020 |
Why?
|
| Vasodilator Agents | 1 | 2012 | 977 | 0.020 |
Why?
|
| Transcription, Genetic | 2 | 2008 | 7722 | 0.020 |
Why?
|
| Chick Embryo | 1 | 2009 | 982 | 0.020 |
Why?
|
| Bone Marrow Cells | 1 | 2015 | 2513 | 0.020 |
Why?
|
| Vasculitis | 1 | 2011 | 519 | 0.020 |
Why?
|
| Fibrinogen | 1 | 2010 | 894 | 0.020 |
Why?
|
| Patch-Clamp Techniques | 1 | 2009 | 964 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2015 | 6386 | 0.020 |
Why?
|
| Computational Biology | 1 | 2018 | 3521 | 0.020 |
Why?
|
| Cell Nucleus | 1 | 2015 | 2969 | 0.020 |
Why?
|
| Pyridines | 1 | 2018 | 2825 | 0.020 |
Why?
|
| Antigens, CD | 1 | 2016 | 4026 | 0.020 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2020 | 2208 | 0.020 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2006 | 300 | 0.020 |
Why?
|
| Substrate Specificity | 1 | 2010 | 1801 | 0.020 |
Why?
|
| Cytokines | 2 | 2015 | 7322 | 0.020 |
Why?
|
| Gene Expression Profiling | 2 | 2015 | 9438 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 2 | 2011 | 5867 | 0.020 |
Why?
|
| Ubiquitination | 1 | 2010 | 1012 | 0.020 |
Why?
|
| Cardiovascular Diseases | 1 | 2011 | 15165 | 0.020 |
Why?
|
| Lac Operon | 1 | 2005 | 238 | 0.020 |
Why?
|
| Receptors, Ghrelin | 1 | 2004 | 25 | 0.020 |
Why?
|
| Receptors, Melanocortin | 1 | 2004 | 25 | 0.020 |
Why?
|
| Hepatocytes | 1 | 2011 | 1211 | 0.020 |
Why?
|
| Keratinocytes | 1 | 2008 | 798 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2008 | 1654 | 0.020 |
Why?
|
| Circadian Rhythm | 1 | 1996 | 2624 | 0.020 |
Why?
|
| Genes, p53 | 1 | 2006 | 755 | 0.020 |
Why?
|
| Peptides | 1 | 2016 | 4409 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2012 | 3913 | 0.010 |
Why?
|
| STAT5 Transcription Factor | 1 | 2004 | 259 | 0.010 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 2010 | 924 | 0.010 |
Why?
|
| Milk Proteins | 1 | 2004 | 169 | 0.010 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2015 | 1519 | 0.010 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2006 | 893 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 2004 | 829 | 0.010 |
Why?
|
| Cell Division | 1 | 2011 | 4568 | 0.010 |
Why?
|
| Heart Atria | 1 | 2009 | 1357 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2010 | 2699 | 0.010 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2013 | 2849 | 0.010 |
Why?
|
| Phentolamine | 1 | 2002 | 104 | 0.010 |
Why?
|
| Immunoprecipitation | 1 | 2005 | 905 | 0.010 |
Why?
|
| Nitric Oxide | 1 | 2011 | 2132 | 0.010 |
Why?
|
| Ghrelin | 1 | 2004 | 266 | 0.010 |
Why?
|
| Lipopolysaccharides | 1 | 2010 | 2216 | 0.010 |
Why?
|
| Mutation | 1 | 2006 | 29786 | 0.010 |
Why?
|
| Oxygen Consumption | 1 | 2008 | 1869 | 0.010 |
Why?
|
| Acetyl-CoA Carboxylase | 1 | 2002 | 78 | 0.010 |
Why?
|
| Uncoupling Agents | 1 | 2001 | 45 | 0.010 |
Why?
|
| Creatine Kinase, MM Form | 1 | 2001 | 12 | 0.010 |
Why?
|
| Age Factors | 2 | 2009 | 18370 | 0.010 |
Why?
|
| Isoproterenol | 1 | 2002 | 399 | 0.010 |
Why?
|
| Adrenergic alpha-Antagonists | 1 | 2002 | 174 | 0.010 |
Why?
|
| Protein Kinases | 1 | 2009 | 1640 | 0.010 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 6 | 1 | 2001 | 122 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2015 | 11031 | 0.010 |
Why?
|
| Genistein | 1 | 2001 | 88 | 0.010 |
Why?
|
| Muscle Contraction | 1 | 2006 | 1240 | 0.010 |
Why?
|
| Green Fluorescent Proteins | 1 | 2006 | 2088 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2015 | 14722 | 0.010 |
Why?
|
| Adrenergic beta-Agonists | 1 | 2002 | 346 | 0.010 |
Why?
|
| Exercise Test | 1 | 2008 | 2074 | 0.010 |
Why?
|
| Myocytes, Cardiac | 1 | 2009 | 1637 | 0.010 |
Why?
|
| Polymorphism, Genetic | 1 | 2011 | 4328 | 0.010 |
Why?
|
| Biological Transport, Active | 1 | 2000 | 349 | 0.010 |
Why?
|
| Lactates | 1 | 2001 | 432 | 0.010 |
Why?
|
| Motivation | 1 | 2009 | 1971 | 0.010 |
Why?
|
| Catalytic Domain | 1 | 2002 | 698 | 0.010 |
Why?
|
| Doxycycline | 1 | 2001 | 326 | 0.010 |
Why?
|
| Infusions, Intravenous | 1 | 2004 | 2274 | 0.010 |
Why?
|
| Androstadienes | 1 | 2001 | 346 | 0.010 |
Why?
|
| Creatine Kinase | 1 | 2001 | 694 | 0.010 |
Why?
|
| Receptors, Estrogen | 1 | 2006 | 2187 | 0.010 |
Why?
|
| Risk | 1 | 2011 | 9687 | 0.010 |
Why?
|
| Rats, Wistar | 1 | 2002 | 1901 | 0.010 |
Why?
|
| Pancreatic Neoplasms | 1 | 2016 | 5256 | 0.010 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2008 | 3760 | 0.010 |
Why?
|
| Neuroblastoma | 1 | 2006 | 1226 | 0.010 |
Why?
|
| Linear Models | 1 | 2008 | 5952 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2006 | 4217 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2015 | 19905 | 0.010 |
Why?
|
| Heart Ventricles | 1 | 2009 | 3821 | 0.010 |
Why?
|
| Fibroblasts | 1 | 2006 | 4161 | 0.010 |
Why?
|
| Binding Sites | 1 | 2005 | 6114 | 0.010 |
Why?
|
| Aging | 1 | 2015 | 8664 | 0.010 |
Why?
|
| Animals, Genetically Modified | 1 | 2001 | 1549 | 0.010 |
Why?
|
| Adenosine Triphosphate | 1 | 2001 | 2025 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2009 | 13989 | 0.010 |
Why?
|
| Coronary Artery Disease | 1 | 2013 | 6487 | 0.010 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2002 | 2455 | 0.010 |
Why?
|
| Prevalence | 1 | 2009 | 15226 | 0.010 |
Why?
|
| Weight Gain | 1 | 2002 | 2292 | 0.010 |
Why?
|
| Adolescent | 2 | 2011 | 85781 | 0.010 |
Why?
|
| Cell Membrane | 1 | 2001 | 3748 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2001 | 6622 | 0.010 |
Why?
|
| Hippocampus | 1 | 2002 | 3675 | 0.010 |
Why?
|
| Genotype | 1 | 2004 | 12951 | 0.010 |
Why?
|
| Pregnancy | 1 | 2008 | 29144 | 0.000 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2008 | 20129 | 0.000 |
Why?
|
| Young Adult | 1 | 2011 | 56430 | 0.000 |
Why?
|
| Aged, 80 and over | 1 | 2009 | 57776 | 0.000 |
Why?
|
| Child | 1 | 2012 | 77709 | 0.000 |
Why?
|
| Neoplasms | 1 | 2011 | 21683 | 0.000 |
Why?
|